Influenza virus vaccine trivalent - KaketsukenAlternative Names: KD-FLU (TIV); Trivalent inactivated influenza virus vaccine - Kaketsuken
Latest Information Update: 02 Jun 2016
At a glance
- Originator Kaketsuken
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 02 Jun 2016 Discontinued - Phase-II/III for Influenza virus infections prevention (In children) in Japan (SC) before June 2016